Epidemiology and outcomes of acute encephalitis

Current Opinion in Neurology

Volumn 28, Issue 3, 2015, Pages 277-282

  Venkatesan, Arun ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute flaccid paralysis; autoimmune encephalitis; herpes simplex virus; prognosis; viral encephalitis

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER;

BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; ENCEPHALITIS; ENCEPHALOMYELITIS; EPILEPTIC STATE; FLACCID PARALYSIS; HERPES SIMPLEX ENCEPHALITIS; HUMAN; MORTALITY; PHYSICAL DISABILITY; PROGNOSIS; REVIEW; SURVIVOR; THROMBOCYTOPENIA; WEST NILE VIRUS; ACUTE DISEASE; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; COGNITION DISORDERS; COMPLICATION; TREATMENT OUTCOME;

ACUTE DISEASE; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; COGNITION DISORDERS; ENCEPHALITIS; HUMANS; TREATMENT OUTCOME;

EID: 84929457923     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000199     Document Type: Review

References (56)

1. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013; 57:1114-1128.
2. George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PLoS One 2014; 9:e104169.
3. Vora NM, Holman RC, Mehal JM, et al. Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology 2014; 82: 443-451.
4. Huppatz C, Durrheim DN, Levi C, et al. Etiology of encephalitis in Australia, 1990-2007. Emerg Infect Dis 2009; 15:1359-1365.
5. Barbadoro P, Marigliano A, Ricciardi A, et al. Trend of hospital utilization for encephalitis. Epidemiol Infect 2012; 140:753-764.
6. Bernard S, Mailles A, Stahl JP. Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data. Epidemiol Infect 2013; 141:2256-2268.
7. Kulkarni MA, Lecocq AC, Artsob H, et al. Epidemiology and aetiology of encephalitis in Canada, 1994-2008: a case for undiagnosed arboviral agents? Epidemiol Infect 2013; 141:2243-2255.
8. Granerod J, Cousens S, Davies NW, et al. New estimates of incidence of encephalitis in England. Emerg Infect Dis 2013; 19: 9.
9. Khetsuriani N, Holman RC, Anderson LJ. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis 2002; 35: 175-182.
10. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006; 43:1565-1577.
11. Mailles A, Stahl JP. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009; 49:1838-1847.
12. Davison KL, Crowcroft NS, Ramsay ME, et al. Viral encephalitis in England, 1989-1998: what did we miss? Emerg Infect Dis 2003; 9:234-240.
13. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, populationbased prospective study. Lancet Infect Dis 2010; 10:835-844.
14. Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology 2015; 27:359-366.
15. Thakur KT, Motta M, Asemota AO, et al. Predictors of outcome in acute encephalitis. Neurology 2013; 81:793-800.
16. Sonneville R, Gault N, de Montmollin E, et al. Clinical spectrum and outcomes of patients with encephalitis requiring intensive care. Eur J Neurol 2015; 22: 6-e1.
17. Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol 2014; 27:361-368.
18. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014; 13:276-286.
19. De Camilli P, Thomas A, Cofiell R, et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med 1993; 178:2219-2223.
20. Solimena M, Folli F, Aparisi R, et al. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990; 322: 1555-1560.
21. McKeon A, Martinez-Hernandez E, Lancaster E, et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 2013; 70:44-50.
22. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008; 71:1291-1292.
23. Carvajal-Gonzá lez A, Leite MI, Waters P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 2014; 137:2178-2192.
24. Balint B, Jarius S, Nagel S, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology 2014; 82:1521-1528.
25. Kincaid O, Lipton HL. Viral myelitis: an update. Curr Neurol Neurosci Rep 2006; 6:469-474.
26. Ayscue P, Van Haren K, Sheriff H, et al. Acute flaccid paralysis with anterior myelitis-California, June 2012-June 2014. MMWR Morb Mortal Wkly Rep 2014; 63:903-906.
27. Pastula DM, Aliabadi N, Haynes AK, et al. Acute neurologic illness of unknown etiology in children-Colorado, August-September 2014. MMWR Morb Mortal Wkly Rep 2014; 63:901-902.
28. Kreuter JD, Barnes A, McCarthy JE, et al. A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med 2011; 135:793-796.
29. Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. Prevention CfDCa: enterovirus surveillance-United States, 1970-2005. MMWR Surveill Summ 2006; 55:1-20.
30. Michaeli O, Kassis I, Shachor-Meyouhas Y, et al. Long-term motor and cognitive outcome of acute encephalitis. Pediatrics 2014; 133:e546-e552.
31. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res 2006; 71:141-148.
32. Tan IL, McArthur JC, Venkatesan A, Nath A. Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology 2012; 79:2125-2132.
33. McGrath N, Anderson NE, Croxson MC, Powell KF. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 1997; 63:321-326.
34. Raschilas F, Wolff M, Delatour F, et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 2002; 35:254-260.
35. Emig M, Apple DJ. Severe West Nile virus disease in healthy adults. Clin Infect Dis 2004; 38:289-292.
36. Sutter R, Kaplan PW, Cervenka MC, et al. Electroencephalography for diagnosis and prognosis of acute encephalitis. Clin Neurophysiol 2014.
37. Tsukahara H, Fujii Y, Matsubara K, et al. Prognostic value of brain injury biomarkers in acute encephalitis/encephalopathy. Pediatr Int 2013; 55: 461-464.
38. Sellner J, Davies NW, Howard RS, Petzold A. Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis. Eur J Neurol 2014; 21:845-850.
39. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986; 314:144-149.
40. Sili U, Kaya A, Mert A. Group HES: herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol 2014; 60:112-118
41. To TM, Soldatos A, Sheriff H, et al. Insights into pediatric herpes simplex encephalitis from a cohort of 21 children from the California Encephalitis Project, 1998-2011. Pediatr Infect Dis J 2014; 33:1287-1288
42. Schleede L, Bueter W, Baumgartner-Sigl S, et al. Pediatric herpes simplex virus encephalitis: a retrospective multicenter experience. J Child Neurol 2013; 28:321-331
43. Linnoila JJ, Rosenfeld MR, Dalmau J. Neuronal surface antibody-mediated autoimmune encephalitis. Semin Neurol 2014; 34:458-466.
44. Stahl JP, Mailles A. What is new about epidemiology of acute infectious encephalitis? Curr Opin Neurol 2014; 27:337-341.
45. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12:157-165.
46. Sejvar JJ, Curns AT, Welburg L, et al. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol 2008; 2:477-499.
47. Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007; 44:1617-1624.
48. Hart J, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis 2014; 14:248.
49. Beattie GC, Glaser CA, Sheriff H, et al. Encephalitis with thalamic and basal ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis 2013; 56:825-832.
50. Einsiedel L, Kat E, Ravindran J, et al. MR findings in Murray Valley encephalitis. AJNR Am J Neuroradiol 2003; 24:1379-1382.
51. Speers DJ, Flexman J, Blyth CC, et al. Clinical and radiological predictors of outcome for Murray Valley encephalitis. Am J Trop Med Hyg 2013; 88: 481-489.
52. Przelomski MM, O'Rourke E, Grady GF, et al. Eastern equine encephalitis in Massachusetts: a report of 16 cases, 1970-1984. Neurology 1988; 38:736-739.
53. Silverman MA, Misasi J, Smole S, et al. Eastern equine encephalitis in children, Massachusetts and New Hampshire, USA, 1970-2010. Emerg Infect Dis 2013; 19:194-201.
54. Ma J, Jiang L. Outcome of children with Japanese encephalitis and predictors of outcome in southwestern China. Trans R Soc Trop Med Hyg 2013; 107:660-665.
55. Logar M, Arnez M, Kolbl J, et al. Comparison of the epidemiological and clinical features of tick-borne encephalitis in children and adults. Infection 2000; 28:74-77.
56. Fowler A ° , Forsman L, Eriksson M, Wickström R. Tick-borne encephalitis carries a high risk of incomplete recovery in children. J Pediatr 2013; 163: 555-560.